Clinical trial
Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute…
NCT00057356 · Cumberland Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00057356 |
|---|---|
| Title | Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure |
| Official title | A Randomized, Double-blind, Placebo-controlled, Dose-ranging Pilot Study Evaluating the Efficacy and Safety of YM087 in Patients With Decompensated Chronic Heart Failure |
| Lead sponsor | Cumberland Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Heart Failure |
| Intervention type | Drug |
| Interventions | conivaptan, placebo |
| Enrollment | 170 |
| Start date | Nov 1, 2002 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Apr 1, 2003 |
| Last update posted | May 2, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: